BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21538175)

  • 41. Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction.
    Agouni A; Tual-Chalot S; Chalopin M; Duluc L; Mody N; Martinez MC; Andriantsitohaina R; Delibegović M
    Biochem Pharmacol; 2014 Dec; 92(4):607-17. PubMed ID: 25451690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.
    McClean PL; Parthsarathy V; Faivre E; Hölscher C
    J Neurosci; 2011 Apr; 31(17):6587-94. PubMed ID: 21525299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
    Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
    ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study investigating the effects of voluntary exercise on capillary stalling and cerebral blood flow in the APP/PS1 mouse model of Alzheimer's disease.
    Falkenhain K; Ruiz-Uribe NE; Haft-Javaherian M; Ali M; ; Michelucci PE; Schaffer CB; Bracko O
    PLoS One; 2020; 15(8):e0235691. PubMed ID: 32857763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a
    Zhou Q; Zheng H; Chen J; Li C; Du Y; Xia H; Gao H
    Metab Brain Dis; 2018 Oct; 33(5):1661-1668. PubMed ID: 29946959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary-challenged mice with Alzheimer-like pathology show increased energy expenditure and reduced adipocyte hypertrophy and steatosis.
    Schreyer S; Berndt N; Eckstein J; Mülleder M; Hemmati-Sadeghi S; Klein C; Abuelnor B; Panzel A; Meierhofer D; Spranger J; Steiner B; Brachs S
    Aging (Albany NY); 2021 Apr; 13(8):10891-10919. PubMed ID: 33864446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance.
    Aberdein N; Dambrino RJ; do Carmo JM; Wang Z; Mitchell LE; Drummond HA; Hall JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R478-R488. PubMed ID: 29351427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmented Insulin and Leptin Resistance of High Fat Diet-Fed APPswe/PS1dE9 Transgenic Mice Exacerbate Obesity and Glycemic Dysregulation.
    Lee YH; Hsu HC; Kao PC; Shiao YJ; Yeh SH; Shie FS; Hsu SM; Yeh CW; Liu HK; Yang SB; Tsay HJ
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP.
    Li L; Zhang X; Yang D; Luo G; Chen S; Le W
    Neurobiol Aging; 2009 Jul; 30(7):1091-8. PubMed ID: 18063223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes.
    van Heusden FC; van Nifterick AM; Souza BC; França ASC; Nauta IM; Stam CJ; Scheltens P; Smit AB; Gouw AA; van Kesteren RE
    Alzheimers Res Ther; 2023 Aug; 15(1):142. PubMed ID: 37608393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high-fat diet exacerbates the Alzheimer's disease pathology in the hippocampus of the App
    Mazzei G; Ikegami R; Abolhassani N; Haruyama N; Sakumi K; Saito T; Saido TC; Nakabeppu Y
    Aging Cell; 2021 Aug; 20(8):e13429. PubMed ID: 34245097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice.
    Wilcox JM; Consoli DC; Tienda AA; Dixit S; Buchanan RA; May JM; Nobis WP; Harrison FE
    Neurobiol Dis; 2021 Oct; 158():105486. PubMed ID: 34450329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.
    Pistell PJ; Zhu M; Ingram DK
    Neuroscience; 2008 Mar; 152(3):594-600. PubMed ID: 18304749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyanidin 3-O-β-glucopyranoside activates peroxisome proliferator-activated receptor-γ and alleviates cognitive impairment in the APP(swe)/PS1(ΔE9) mouse model.
    Song N; Zhang L; Chen W; Zhu H; Deng W; Han Y; Guo J; Qin C
    Biochim Biophys Acta; 2016 Sep; 1862(9):1786-800. PubMed ID: 27240542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.